Vascular endothelial growth factor: A translational view in oral non-communicable diseases
Author
dc.contributor.author
Niklander, Sven
Author
dc.contributor.author
Bordagaray San Martín, María José
Author
dc.contributor.author
Fernández, Alejandra
Author
dc.contributor.author
Hernández Ríos, Emma Marcela
Admission date
dc.date.accessioned
2021-10-14T15:22:12Z
Available date
dc.date.available
2021-10-14T15:22:12Z
Publication date
dc.date.issued
2021
Cita de ítem
dc.identifier.citation
Biomolecules 2021, 11, 85.
es_ES
Identifier
dc.identifier.other
10.3390/biom11010085
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/182267
Abstract
dc.description.abstract
Vascular endothelial growth factors (VEGFs) are vital regulators of angiogenesis that are
expressed in response to soluble mediators, such as cytokines and growth factors. Their physiologic
functions include blood vessel formation, regulation of vascular permeability, stem cell and
monocyte/macrophage recruitment and maintenance of bone homeostasis and repair. In addition,
angiogenesis plays a pivotal role in chronic pathologic conditions, such as tumorigenesis, inflammatory
immune diseases and bone loss. According to their prevalence, morbidity and mortality,
inflammatory diseases affecting periodontal tissues and oral cancer are relevant non-communicable
diseases. Whereas oral squamous cell carcinoma (OSCC) is considered one of the most common
cancers worldwide, destructive inflammatory periodontal diseases, on the other hand, are amongst
the most prevalent chronic inflammatory conditions affecting humans and also represent the main
cause of tooth loss in adults. In the recent years, while knowledge regarding the role of VEGF
signaling in common oral diseases is expanding, new potential translational applications emerge.
In the present narrative review we aim to explore the role of VEGF signaling in oral cancer and
destructive periodontal inflammatory diseases, with emphasis in its translational applications as
potential biomarkers and therapeutic targets.
es_ES
Patrocinador
dc.description.sponsorship
Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)
CONICYT FONDECYT 1200098
es_ES
Lenguage
dc.language.iso
en
es_ES
Publisher
dc.publisher
MDPI
es_ES
Type of license
dc.rights
Attribution-NonCommercial-NoDerivs 3.0 United States